Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market. Our capabilities in the areas of tech transfer, process and pharmaceutical product development, formulation development, production, scale-up and validation, and analytical method development allow us to partner with clients from development through commercialization or at any point along the way.

From our site in Tallinn, Estonia we provide custom organic synthesis and contract research and development services. Our talented team of 30 employees in Tallinn work closely with Cambrex’s R&D specialists across our global network. Most activity at this site involves providing expertise in managing research programs, producing reference standards, initial gram quantities of pharmaceutical products and non-GMP scale-up to kilogram quantities.

The facility is located adjacent to Tallinn University of Technology’s campus, allowing for strong collaborative links with the University’s analytical and chemistry departments.